WHO ICTRP trial

A study to compare additional treatment with Subconjunctival and Topical…

CTRI/2018/07/014812 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2018/07/014812
Public title A study to compare additional treatment with Subconjunctival and Topical Bevacizumab (a drug known to reduce recurrence in various studies) combined with Pterygium surgery versus Pterygium surgery alone on recurrence of pterygium : A multi centric trial
Scientific title Comparative study of adjunctive treatment with Subconjunctival and Topical Bevacizumab combined with Pterygium excision and conjunctival autograft versus Pterygium excision with conjunctival autograft alone on recurrence after excision of primary pterygium : A multi centric trial
Primary sponsor Office of DGAFMS Ministry of Defence
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: null- Patients of Pterygium who meet the inclusion criteria and give their consent for trial
Interventions Intervention1: Pterygium Excision and conjunctival autograft.: This is Standard of care. Patients will undergo Pterygium Excision and conjunctival autograft using fibrin glue Control Intervention1: Pterygium Excision and conjunctival…
Registration date Nov 7, 2018
Target size 1749
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations